In: AIFA, editor
And not just access but I think in terms of the research that is being done, representation as well, right, because who is utilizing this right now is not necessarily representative of every group that could really benefit from this
A higher metabolic rate translates into increased flexibility in how the body metabolizes fats and carbs, which can assist type 2 diabetics and obese individuals in managing long-term health
Figure 1 The present review aims to elucidate and describe the molecular mechanisms of the GLP-1RA drugs, semaglutide and liraglutide, and their effectiveness and potential as a therapeutic option against obesity
BCBS Medicare and Medicaid plans Does Blue Cross Blue Shield cover Mounjaro for weight loss
Additional beneficial changes to the companys pipeline also contributed to their growth, including the acquisition of Imago BioSciences in November 2022 for a total equity value of $1.35 billion and expanding their hematology portfolio, as well as agreements with Moderna and Kelun-Biotech, the latter with which they will be developing seven investigational preclinical antibody-drug conjugates for cancer treatment